Regentis Biomaterials Ltd.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Regentis Biomaterials Ltd. is a regenerative medicine company focused on developing and commercializing tissue repair solutions for damaged cartilage, bone, and other tissues. The company’s core platform, Gelrin, uses degradable hydrogel implants designed to support the regeneration of diseased or injured tissue, with a particular emphasis on orthopedic applications. Its lead product, GelrinC, is a cell-free, off-the-shelf hydrogel implant intended for knee cartilage repair, making it relevant to sports medicine and early-stage osteoarthritis care. Regentis Biomaterials serves the broader healthcare and biomedical device markets through products aimed at restoring tissue function and improving patient outcomes. The company is headquartered in Herzliya, Israel.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Dr. Ehud Geller Ph.D.
- Employees
- 3
- Headquarters
- Herzliya, Israel
- Website
- www.regentis.co.il